Past Winners of the Richard J. Bolte, Sr., Award for Supporting Industries
Eugene Garfield, the 2007 winner, addresses the crowd at Heritage Day.
Alan Walton, 2013
Alan Walton is senior general partner at Oxford Bioscience Partners. Before his 20-year tenure at Oxford Partners, Walton founded and was president and CEO of University Genetics, one of the first biotechnology companies. He previously held professorships at Harvard Medical School, Indiana University, and Case Western Reserve University, where he was director of the Macromolecular Biology Center.
Walton is best known for his work on the invention and commercialization of differential gene analysis, a diagnostic tool now widely used in identifying types of cancer and other diseases, as well as financing and promoting the initial sequencing of the human genome. He also financed the team that developed baby-formula additives that have inhibited or prevented mental retardation in premature and newborn babies worldwide.
Walton has served on the boards of 20 companies. He is also the winner of several international awards and honors, including the Israel Medal of Science. In 2012 he was appointed as an Officer of the Most Excellent Order of the British Empire by Queen Elizabeth II in recognition of his services to the U.K. biotechnology industry and for promoting advances in Anglo-American biological commerce. He has authored over 120 scientific articles and 10 books.
Walton holds a Ph.D. in chemistry and a D.Sc. in biological chemistry from Nottingham University, and in 2005 received an honorary L.L.D. degree from Nottingham University for his lifetime achievement in life sciences. In 2007 he was elected Emeritus University Adjunct Professor at Case Western Reserve University.
G. Steven Burrill, 2012
G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 40 years. An early biotech pioneer, Burrill is one of the original architects of the industry and one of its most avid and sustained developers. He is currently the CEO of Burrill and Company, a diversified global financial-services firm focused on the life-sciences industry, and serves on the boards of directors of Catalyst Biosciences, Depomed, NewBridge, Novadaq, Proventys, Targacept, and XDx.
Before founding Burrill and Company in 1994 he spent 28 years with Ernst and Young, directing and coordinating the firm’s services to clients in the biotechnology, life-sciences, high-technology, and manufacturing industries worldwide. In 2002 Burrill was recognized as a biotech investment visionary by Scientific American (as one of the “Scientific American 50”). In 2008 he received the BayBio Pantheon DiNA lifetime-achievement award for his worldwide biotech leadership.
In addition to his work with leading life-sciences companies Burrill is a founder and currently chairman of the board of the Foundation for the National Medals of Science and Technology. He also serves as chairman of the San Francisco Mayor’s Biotech Advisory Committee. Burrill chaired the National Research Council study on links in biotechnology between Japan and the United States and was also involved with the U.S.–Japan Science and Technology Agreement Study of Technology Transfer Mechanisms.
Other not-for-profit activities include serving on the board of directors of the Bay Area Science Infrastructure Consortium, BayBio (emeritus), California Healthcare Institute (emeritus), the Exploratorium (emeritus), the Kellogg Center for Biotechnology, the MIT Center for Biomedical Innovation, the National Health Museum (vice chairman), the World Council for Ethical Standards (chairman), the Vilas County (Wisconsin) Economic Development Group (chairman), BIO Ventures for Global Health (BVGH), the University of Wisconsin Extension, the Scientific American Board of Advisers, and the Harvard Medical School Genetics Advisory Council. He is an adviser to the University of Illinois Institute for Genomic Biology, the University of Wisconsin College of Agriculture and Life Sciences, the University of Minnesota College of Biological Sciences, and Duke University. He is also an adjunct professor at the University of California, San Francisco.
Lawrence Evans, 2011
Lawrence B. Evans founded Aspen Technology in 1981 and served as chairman and CEO until 2002. During that time the company grew from a start-up to the leading provider of software and solutions to the chemical-process manufacturing industries. From 1962 to 1990 Evans was also professor of chemical engineering at the Massachusetts Institute of Technology, where he was well known for his work in computer-aided process design and process control.
In 1982 the Computing and Systems Technology Division of the American Institute of Chemical Engineers gave Evans its Computing in Chemical Engineering Award. In 1997 Ernst and Young named him Entrepreneur of the Year for high technology in the New England region. Fortune magazine called him one of seven U.S. Heroes of Manufacturing in 1999. That same year he received the University of Michigan College of Engineering’s Alumni Society Merit Award from the Department of Chemical Engineering.
In 2001 Evans was elected to the National Academy of Engineering. Chemical Engineering magazine chose him for the 2002 Award for Personal Achievement in Chemical Engineering. In 2003 he was elected to the University of Oklahoma College of Engineering Distinguished Graduates Society, and he received the Engineering Achievement Award from the Engineering Construction Contracting Association. In 2007 Evans served as president of the American Institute of Chemical Engineers.
Evans holds a bachelor’s degree from the University of Oklahoma. He earned both a master’s degree and a doctorate in chemical engineering from the University of Michigan.
C. Berdon Lawrence, 2010
C. Berdon Lawrence is chairman of the board of Kirby Corporation, a tank-barge company that moves petrochemicals and petroleum products on inland waterways. Kirby operates 900 tank barges and 200 towboats and employs more than 3,100 people. Kirby also provides diesel-engine services for marine, power-generation, industrial, and railroad markets.
Headquartered in Houston, Kirby Petroleum Company was founded in 1921 by John Henry Kirby. In the mid-1980s the company began concentrating on the tank-barge business through a series of acquisitions. In 1999 Kirby acquired Hollywood Marine from Lawrence and Lawrence became Kirby’s chairman.
A founder, with his wife, of the Rolanette and Berdon Lawrence Bone Disease Program of Texas, Lawrence is also director of the Houston Maritime Association, a member of the Texas World Presidents’ Organization, and a board member of Kinder Morgan Energy Partners. Lawrence is chairman emeritus of the Waterways Council. He has also chaired the Inland Waterways Users Board, the National Waterways Conference, the American Waterways Operators, the Clean Channel Association, and the Texas Waterways Operators.
Lawrence received both a B.B.A. and an M.B.A. from Tulane University.
David and Alice Schwartz, 2009
For almost 60 years, David and Alice Schwartz have served as models of entrepreneurship and innovation. The company they cofounded originally to create and sell tobacco mosaic virus, Bio-Rad Laboratories, has evolved into a global enterprise that manufactures and distributes products to more than 85,000 customers in the life science research and clinical diagnostics markets.
David Schwartz grew up in Brooklyn, New York. After serving in World War II as part of the Army Signal Corps, he moved to California’s San Francisco Bay Area to attend college. He first met Alice in a class at the University of California, Berkeley, where he earned a degree in chemistry and she earned a degree in biochemistry. During a student bridge game in 1952, the couple happened upon the idea to start a company that would accelerate the scientific discovery process by providing useful products to researchers. With about $700 of their own money and some additional funds from a cousin, they launched Bio-Rad.
While the Schwartzes’ first product, tobacco mosaic virus, did not take off, they soon developed more marketable research products that resulted in the company’s tremendous growth. Today Bio-Rad employs over 5,000 people in an international network of operations, with headquarters in Hercules, California. The firm is renowned worldwide among hospitals, universities, and major research institutions, as well as biotechnology and pharmaceutical companies. It has maintained the entrepreneurial spirit of its cofounders and done pioneering work in electrophoresis, DNA amplification, chromatography, multiplexing assays, nucleic acid and protein quantitation, and protein expression. Recently Bio-Rad has grown to over $1.4 billion in revenues.
David Schwartz currently serves as chairman of Bio-Rad, while Alice is a director. He has received a Pittcon Heritage Award and an Ernst and Young Lifetime Achievement Award.
Jerry M. Sudarsky, 2008
Jerry M. Sudarsky, who immigrated to the United States from Russia as a child, became a respected business leader and successful industrialist, applying his experience and know-how to chemical industries, pharmaceuticals, biotechnology, real estate, and engineering.
Jerry M. Sudarsky, principal founder of Alexandria Real Estate Equities, attended the University of Iowa from 1936 to 1939 on a scholarship, where he was pitcher on the baseball team. He briefly spent some time with the Boston Red Sox in spring training before discovering his calling in the biotech industry. Returning to school, he obtained a degree in chemical engineering from Polytechnic Institute of Brooklyn.
In 1946 Sudarsky founded his first company, Pacific Yeast Products, later named Bioferm Corporation, one of the first biotech companies in the world. Bioferm pioneered the production of vitamin B12 and created and marketed the first bio-insecticide products. Sudarsky sold the company in 1960 and joined the United Nations Industrial Development Organization (UNIDO), a United Nations agency dedicated to helping underdeveloped nations develop and improve their industrial base. Working for UNIDO, he helped found Israel Chemicals and served as its chairman from 1968 to 1972. He later served as vice chairman for Daylin, Inc., and Jacobs Engineering Group.
In 1994, using his extensive experience in the design, engineering, construction, and operations of commercial prperties, Sudarsky created Health Science Properties, now known as Alexandria Real Estate Equities, a company that provides laboratory space to the biotech industry. Three years after its inception, Alexandria went public on the New York Stock Exchange with fewer than 10 employees.
Sudarsky and his wife, Milly, have supported many worthy causes and institutions, including the Sudarsky Biochemical Building and the Sudarsky Center for Computational Biology at Hebrew University.
Eugene Garfield, 2007
Eugene Garfield, noted innovator and inventor in the field of citation analysis, received a B.S. and a master's degree in library science from Columbia University and a Ph.D. in structural linguistics from the University of Pennsylvania. His career in scientific communication and information began in 1951 when he joined the Welch Medical Indexing Project at Johns Hopkins University. The goal of the project was to examine problems of medical information retrieval and the application of new methods to indexing biomedical literature. The Welch Project planted the seeds for information discovery and recovery in scientific communication and information science that have distinguished Garfield's career.
In 1955 Garfield produced a contents-page publication covering the social sciences and management literature. Two years later he began producing a similar service covering the literature of interest to pharmaceutical companies. In 1958 Garfield and Joshua Lederberg collaborated on Genetics Citation Index. Garfield began regular publication of the Science Citation Index (SCI) in 1964 through the Institute for Scientific Information, the name his firm assumed in 1960. The SCI was recognized as a basic and fundamental innovation in scientific communication and information science. It covered virtually all disciplines and fields of science, comprehensively indexing all types of sources. Most importantly, the SCI uniquely indexed the references cited in the articles it indexed.
Garfield went on to create new tools including Index Chemicus, Current Contents, The Genuine Article, citation indexes for the social sciences (SSCI), as well as the arts and humanities (A&HCI), Index to Scientific & Technical Proceedings and Books, and others. In 1986 he founded The Scientist, a biweekly newspaper for the research professional, which reports on news and developments within the sciences. He has published more than 1,000 essays in Current Contents over the past 25 years and has published and edited commentaries by the authors of more than 5,000 Citation Classics.
Richard J. Bolte, Sr., 2006
Richard J. Bolte, Sr., founder and chairman of BDP International, was one of the first in his field to envision the potential of information technology for managing and organizing international freight movements. A pioneer in logistics information technology solutions, Bolte made BDP International a recognized leader in the global shipping industry.
Bolte was born and raised in Philadelphia. After military service in Alaska during the Korean War, he earned a bachelor’s degree in business administration from LaSalle University. He holds a doctorate of humane letters from Mt. St. Mary’s College in Emmitsburg, Maryland. Following his graduation from LaSalle, Bolte worked in an entry-level position for a small Philadelphia firm involved with the facilitation of exports. This early experience in exporting, combined with a strong entrepreneurial spirit, led him to establish his own firm in 1966, aptly named the R.J. Bolte Company. Six years later, the company, as a result of a series of mergers and acquisitions, became BDP International.
With Bolte at the helm, BDP International became a customer-driven company, focusing on the importance of information, logistics, and communications to international shippers. From the beginning, BDP has combined the old-fashioned art of listening to its customers with a cutting-edge approach to solutions in logistics and transportation. Today BDP can credit much of its success to its early application of information technology–based solutions to the complex logistics needs of global shippers. The company has grown from a handful of employees in Philadelphia to more than 1,800 worldwide and now operates freight logistics centers in more than 20 cities throughout the United States, with a network of subsidiaries, joint ventures, and strategic partnerships in 140 countries.